Loxam Teri

Track

Insider profile

Loxam Teri's trades of Vaxcyte Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
368.96
Quantity 99,257 +18.5%
Value US$2,869,738
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
450.60
Quantity 9,919 -13.9%
Value US$3,437,471
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
130.33
Quantity 34,204 +49.2%
Value US$566,493
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
85.29
Quantity 1,043 -9.7%
Value US$88,961
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
83.93
Quantity 1,202 -10.1%
Value US$100,885
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
82.89
Quantity 1,136 -8.7%
Value US$94,168
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
81.53
Quantity 215 -1.6%
Value US$17,530
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
80.46
Quantity 146 -1.1%
Value US$11,747
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
80.32
Quantity 6,250
Value US$502,000
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
117.51
Quantity 256 -3.4%
Value US$30,083
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
116.62
Quantity 4,308 -36.7%
Value US$502,387
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
115.32
Quantity 1,445 -11.0%
Value US$166,634
US Vaxcyte Inc (PCVX)
Transaction date
Planned sale
Price
114.64
Quantity 241 -1.8%
Value US$27,628
US Vaxcyte Inc (PCVX)
Transaction date
Proposed sale
Price
113.93
Quantity 6,250
Value US$712,062
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-17 2025-01-15
US Vaxcyte Inc (PCVX)
PlS Planned sale
99,257 +18.5%
368.96
US$2,869,738 		99,257 +18.5% 368.96 US$2,869,738
2025-01-17 2025-01-15
US Vaxcyte Inc (PCVX)
PlS Planned sale
9,919 -13.9%
450.60
US$3,437,471 		9,919 -13.9% 450.60 US$3,437,471
2025-01-17 2025-01-15
US Vaxcyte Inc (PCVX)
PlS Planned sale
34,204 +49.2%
130.33
US$566,493 		34,204 +49.2% 130.33 US$566,493
2025-01-17 2025-01-15
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,043 -9.7%
85.29
US$88,961 		1,043 -9.7% 85.29 US$88,961
2025-01-17 2025-01-15
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,202 -10.1%
83.93
US$100,885 		1,202 -10.1% 83.93 US$100,885
2025-01-17 2025-01-15
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,136 -8.7%
82.89
US$94,168 		1,136 -8.7% 82.89 US$94,168
2025-01-17 2025-01-15
US Vaxcyte Inc (PCVX)
PlS Planned sale
215 -1.6%
81.53
US$17,530 		215 -1.6% 81.53 US$17,530
2025-01-17 2025-01-15
US Vaxcyte Inc (PCVX)
PlS Planned sale
146 -1.1%
80.46
US$11,747 		146 -1.1% 80.46 US$11,747
2025-01-15 2025-01-15
US Vaxcyte Inc (PCVX)
PrS Proposed sale
6,250
80.32
US$502,000 		6,250 80.32 US$502,000
2024-09-18 2024-09-17
US Vaxcyte Inc (PCVX)
PlS Planned sale
256 -3.4%
117.51
US$30,083 		256 -3.4% 117.51 US$30,083
2024-09-18 2024-09-17
US Vaxcyte Inc (PCVX)
PlS Planned sale
4,308 -36.7%
116.62
US$502,387 		4,308 -36.7% 116.62 US$502,387
2024-09-18 2024-09-17
US Vaxcyte Inc (PCVX)
PlS Planned sale
1,445 -11.0%
115.32
US$166,634 		1,445 -11.0% 115.32 US$166,634
2024-09-18 2024-09-17
US Vaxcyte Inc (PCVX)
PlS Planned sale
241 -1.8%
114.64
US$27,628 		241 -1.8% 114.64 US$27,628
2024-09-17 2024-09-17
US Vaxcyte Inc (PCVX)
PrS Proposed sale
6,250
113.93
US$712,062 		6,250 113.93 US$712,062